Trading Halt: Halt Status Updated at 7:30:00 AM ET: Quotation Resumption: News and Resumption Times

BenzingaNov 20 20:30

Express News | NewAmsterdam Pharma Announces Positive Topline Data From Pivotal Phase 3 Tandem Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 Mg and Ezetimibe 10 Mg in Patients With Ascvd or Ascvd Risk Factors and/or Hefh

BreakingsNov 20 20:00

NewAmsterdam Pharma Announces Positive Topline Data From Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 Mg and Ezetimibe 10 Mg in Patients With ASCVD or ASCVD Risk Factors And/or HeFH

GlobeNewswireNov 20 20:00

Trading Halt: Halted at 6:55:00 A.m. ET - Trading Halt: Halt News Pending

BenzingaNov 20 19:55

NewAmsterdam Pharma Presents Additional Data From Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients With Heterozygous Familial Hypercholesterolemia at AHA Scientific Sessions 2024

GlobeNewswireNov 19 04:20

Form 144 | NewAmsterdam Pharma(NAMS.US) Insider Proposes to Sell 38.81 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 13, $NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM)(NAMSW.US)$、$NewAmsterdam Pharma(NAMS.US)$ Insider NAP PoolCo B.V. intends to sell 1.55 million shares of its common

Futu NewsNov 14 05:29